Systematic review / meta-analysis / 2017
Coffee consumption was linked to lower risks of all-cause mortality, cardiovascular disease, and cancer, though pregnancy harms were observed.
An umbrella review analyzed 201 meta-analyses of observational studies and 17 meta-analyses of interventional studies on coffee and multiple health outcomes. Intakes of 3 to 4 cups a day versus none showed the largest relative risk reductions for all-cause mortality (RR 0.83, 95% CI 0.79 to 0.88), cardiovascular mortality (RR 0.81, 95% CI 0.72 to 0.90), and cardiovascular disease (RR 0.85, 95% CI 0.80 to 0.90). High versus low intake was linked to lower incident cancer risk (RR 0.82, 95% CI 0.74 to 0.89) alongside lower risk of neurological, metabolic, and liver conditions. Conversely, high consumption during pregnancy was linked to higher risk of low birth weight (OR 1.31), preterm birth, and pregnancy loss, and coffee was associated with fracture risk in women.
Shows an association, not proof of cause and effect.
- Study type
- Umbrella review of meta-analyses
- Who was studied
- Adult populations across 201 observational and 17 interventional meta-analyses
- What was measured
- Multiple health outcomes including mortality, CVD, cancer, pregnancy, and liver conditions
THE PAPER
Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes.
Poole R, Kennedy OJ, Roderick P, Fallowfield JA, Hayes PC, Parkes J. BMJ, 2017.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.